Authors:
Battaglia, G
Bruno, V
Pisani, A
Centonze, D
Catania, MV
Calabresi, P
Nicoletti, F
Citation: G. Battaglia et al., Selective blockade of type-1 metabotropic glutamate receptors induces neuroprotection by enhancing gabaergic transmission, MOL CELL NE, 17(6), 2001, pp. 1071-1083
Authors:
Melchiorri, D
Bruno, V
Besong, G
Ngomba, RT
Cuomo, L
De Blasi, A
Copani, A
Moschella, C
Storto, M
Nicoletti, F
Lepperdinger, G
Passarelli, F
Citation: D. Melchiorri et al., The mammalian homologue of the novel peptide Bv8 is expressed in the central nervous system and supports neuronal survival by activating the MAP kinase/PI-3-kinase pathways, EUR J NEURO, 13(9), 2001, pp. 1694-1702
Authors:
Bruno, V
Battaglia, G
Copani, A
Cespedes, VM
Galindo, MF
Cena, V
Sanchez-Prieto, J
Gasparini, F
Kuhn, R
Flor, PJ
Nicoletti, F
Citation: V. Bruno et al., An activity-dependent switch from facilitation to inhibition in the control of excitotoxicity by group I metabotropic glutamate receptors, EUR J NEURO, 13(8), 2001, pp. 1469-1478
Authors:
Copani, A
Uberti, D
Sortino, MA
Bruno, V
Nicoletti, F
Memo, M
Citation: A. Copani et al., Activation of cell cycle-associated proteins in neuronal death: a mandatory or dispensable path?, TRENDS NEUR, 24(1), 2001, pp. 25-31
Authors:
D'Onofrio, M
Cuomo, L
Battaglia, G
Ngomba, RT
Storto, M
Kingston, AE
Orzi, F
De Blasi, A
Di Iorio, P
Nicoletti, F
Bruno, V
Citation: M. D'Onofrio et al., Neuroprotection mediated by glial group-II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways, J NEUROCHEM, 78(3), 2001, pp. 435-445
Authors:
Milella, E
Ramires, PA
Brescia, E
La Sala, G
Di Paola, L
Bruno, V
Citation: E. Milella et al., Physicochemical, mechanical, and biological properties of commercial membranes for GTR, J BIOMED MR, 58(4), 2001, pp. 427-435
Authors:
Bonina, FP
Arenare, L
Ippolito, R
Boatto, G
Battaglia, G
Bruno, V
de Caprariis, P
Citation: Fp. Bonina et al., Synthesis, pharmacokinetics and anticonvulsant activity of 7-chlorokynurenic acid prodrugs, INT J PHARM, 202(1-2), 2000, pp. 79-88
Authors:
Bruno, V
Battaglia, G
Ksiazek, I
van der Putten, H
Catania, MV
Giuffrida, R
Lukic, S
Leonhardt, T
Inderbitzin, W
Gasparini, F
Kuhn, R
Hampson, DR
Nicoletti, F
Flor, PJ
Citation: V. Bruno et al., Selective activation of mGlu4 metabotropic glutamate receptors is protective against excitotoxic neuronal death, J NEUROSC, 20(17), 2000, pp. 6413-6420
Authors:
Bruno, V
Copani, A
Besong, G
Scoto, G
Nicoletti, F
Citation: V. Bruno et al., Neuroprotective activity of chemokines against N-methyl-D-aspartate or beta-amyloid-induced toxicity in culture, EUR J PHARM, 399(2-3), 2000, pp. 117-121
Authors:
Battaglia, G
La Russa, M
Bruno, V
Arenare, L
Ippolito, R
Copani, A
Bonina, F
Nicoletti, F
Citation: G. Battaglia et al., Systemically administered D-glucose conjugates of 7-chlorokynurenic acid are centrally available and exert anticonvulsant activity in rodents, BRAIN RES, 860(1-2), 2000, pp. 149-156
Authors:
Ciccarelli, R
Di Iorio, P
Bruno, V
Battaglia, G
D'Alimonte, I
D'Onofrio, M
Nicoletti, F
Caciagli, F
Citation: R. Ciccarelli et al., Activation of A(1) adenosine or mGlu3 metabotropic glutamate receptors enhances the release of nerve growth factor and S-100 beta protein from cultured astrocytes, GLIA, 27(3), 1999, pp. 275-281
Authors:
Bruno, V
Battaglia, G
Kingston, A
O'Neill, MJ
Catania, MV
Di Grezia, R
Nicoletti, F
Citation: V. Bruno et al., Neuroprotective activity of the potent and selective mGlula metabotropic glutamate receptor antagonist, (+)-2-methyl-4 caroxyphenylglycine (LY367385): comparison with LY357366, a broader spectrum antagonist with equal affinity for mGlula and mGlu5 receptors, NEUROPHARM, 38(2), 1999, pp. 199-207
Authors:
Nicoletti, F
Bruno, V
Catania, MV
Battaglia, G
Copani, A
Barbagallo, G
Cena, V
Sanchez-Prieto, J
Spano, PF
Pizzi, M
Citation: F. Nicoletti et al., Group-I metabotropic glutamate receptors: hypotheses to explain their dualrole in neurotoxicity and neuroprotection, NEUROPHARM, 38(10), 1999, pp. 1477-1484
Authors:
Gasparini, F
Bruno, V
Battaglia, G
Lukic, S
Leonhardt, T
Inderbitzin, W
Laurie, D
Sommer, B
Varney, MA
Hess, SD
Johnson, EC
Kuhn, R
Urwyler, S
Sauer, D
Portet, C
Schmutz, M
Nicoletti, F
Flor, PJ
Citation: F. Gasparini et al., (R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo, J PHARM EXP, 289(3), 1999, pp. 1678-1687